Q&A Session 3 – ASG Webinar – 11/11

This webinar is hosted by Amyloidosis Support Group. In this chapter of the webinar Mathew S. Maurer, MD, Cardiologist, Director, Cardiac Amyloidosis Center, Professor of Medicine, Columbia University Medical Center; Nitasha Sarswat, MD, Director of Infiltrative Cardiomyopathy Program, University of Chicago Medicine; Lynn Punnoose, MD, Director, Vanderbilt Advanced Heart Failure/Transplant Fellowship Program, Vanderbilt University Medical Center; Sami Khella, MD, Chief of Neurology, Penn Presbyterian Medical Center; Michael Maitland, MD, PhD, Sr. Director, Clinical Development, Intellia Therapeutics; Colleen Moffitt, PharmD, MS, US ATTR Medical Director, Alnylam Pharmaceuticals; Gustavo Buchele, MD, PhD, Executive Director, Clinical Development, Ionis Pharmaceuticals; Abbas Ebrahim, MD, Sr. Medical Director, US Medical Affairs, Rare Disease, Pfizer; Lori Baylor, PhD, Medical Director, Rare Cardiology, US Medical Affairs, Rare Disease, Pfizer, and Spencer Guthrie, Cofounder & Chief Operating Officer, Attralus, Inc., South San Francisco, CA presents Q/A session.